KNSA
KINIKSA PHARMA (KNSA)
NASDAQ
$75.70+$0.47 (+0.63%)
Price as of Oct 02, 2026 4:20 PM EDT
  • $3.2B
    Market Cap
  • 100.75%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 72
Valuation
KNSA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 93
Valuation
KNSA
vs History
vs S&P 500
3-Month Momentum
23.97%
12-Month Momentum
105.18%
3-Month Risk Adjusted Momentum
80.66%
12-Month Risk Adjusted Momentum
215.61%

True Yield

N/A
Valuation
KNSA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 71
Valuation
KNSA
vs History
vs S&P 500
Ohlson's O-Score
10